Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications used to treat type 2 diabetes and obesity, have seen a significant surge in usage in recent years. However, these drugs may potentially impact the effectiveness of oral contraceptives, leading to concerns about unintended pregnancies[1][4]. Interactions with Oral Contraceptives GLP-1 receptor agonists, such as Ozempic, Wegovy, […]
Category Archives: Cagrilintide
Glucagon-like peptide-1 (GLP-1) receptor agonists, such as tirzepatide, have shown promise not only in managing type 2 diabetes and obesity but also in reducing inflammation, a common underlying factor in various chronic diseases. This article explores the mechanisms and clinical evidence supporting the anti-inflammatory effects of these medications. Mechanisms of Anti-Inflammatory Action Clinical Evidence of […]
Lyophilized peptides are essential components in many research and clinical settings. Proper storage of these peptides is crucial to maintain their stability and effectiveness. Here are some detailed guidelines on how to store lyophilized peptide powders until you are ready to reconstitute them. Understanding Lyophilized Peptides Lyophilization, also known as freeze-drying, is a process used […]
Cagrilintide: The Amylin Analogue Shaking Up the Weight Loss Landscape While glucagon-like peptide-1 (GLP-1) agonists like semaglutide and tirzepatide have been making waves in the world of weight management, a novel amylin analogue called cagrilintide is emerging as a potential game-changer. Unlike its GLP-1 counterparts, cagrilintide takes a distinct approach by targeting the amylin pathway, […]